Abelacimab Prevents VTE After Total Knee Arthroplasty

Single, postoperative IV dose of abelacimab superior to enoxaparin for preventing venous thromboembolism, with no increase in bleeding risk
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Orthopedics, Pharmacy, Surgery, Conference News, Source Type: news